PVM Researcher Shares Insights about African Cancer Research on Global Cancer Information Website
Friday, February 21st, 2020 - The online platform ecancer, which seeks to raise the standards of care for cancer patients across the world through education, recently posted a video of an interview with Dr. Sulma Mohammed, professor of cancer biology in Purdue Veterinary Medicine’s Department of Comparative Pathobiology.
BMS Scholar Helps Lead Team Studying Worldwide Patented Innovations Available for Gene Therapy Treatment
Friday, February 14th, 2020 - The global gene therapy market is expected to reach $13 billion by 2024 as new treatment options target cancers and other diseases. Dr. Marxa Figueiredo, associate professor of basic medical sciences in the Purdue University College of Veterinary Medicine, has helped lead a team of scientists from Purdue and other research institutions around the world who came together to better understand the growing number of worldwide patented innovations available for gene therapy treatment.
Novel techniques for mining patented gene therapies offer promising treatment options for cancers, other diseases
Monday, February 10th, 2020 - The global gene therapy market is expected to reach $13 billion by 2024 as new treatment options target cancers and other diseases. Now, a team of scientists from Purdue University and other research institutions around the world have come together to better understand the growing number of worldwide patented innovations available for gene therapy treatment. They specifically focus on...
Comparative Blood-Brain Barrier Laboratory Seeks to Unlock Mystery of Lung Cancer Brain Metastases
Monday, December 16th, 2019 - The research team at the Comparative Blood-Brain Barrier Laboratory (CBBBL) in the Purdue University College of Veterinary Medicine is conducting studies that aim to improve drug delivery techniques, increase the lung cancer survival rate, and enhance quality of life for patients.
Cancer Research Breakthroughs
Monday, December 16th, 2019 - Although scientists know that the solution to preventing breast cancer won’t come easily, a team of researchers, including Dr. Sophie Lelièvre, professor of cancer pharmacology in Purdue Veterinary Medicine’s Basic Medical Sciences Department, has announced the recent discovery of one of the puzzle pieces to cancer prevention.
PVM Faculty Collaborate for Cancer Research
Monday, December 16th, 2019 - The Purdue Center for Cancer Research (PCCR) is honoring the legacy of Tyler Trent – the Purdue graduate and superfan who died January 1 at age 20 of the rare bone cancer osteosarcoma – through three new collaborative research initiatives, two of which involve Purdue’s College of Veterinary Medicine.
CPB Faculty Member Receives Showalter Trust Grant
Friday, December 6th, 2019 - Dr. Nadia Lanman, research assistant professor in the Department of Comparative Pathobiology, is among 11 early career faculty members at Purdue University who recently received one-year grants from the Ralph W. and Grace M. Showalter Research Trust.
PVM Professors Contribute to Research on Potential New Bladder Cancer Treatment
Friday, November 22nd, 2019 - Two Purdue Veterinary Medicine faculty members played an instrumental role in research involving the Purdue University Center for Cancer Research focused on developing a promising new method of treating bladder cancer using a modified version of the anthrax toxin.
Anthrax may be the next tool in the fight against bladder cancer
Wednesday, November 13th, 2019 - Anthrax may soon help more people win the fight against bladder cancer, which the U.S. Centers for Disease Control and Prevention says strikes about 72,000 Americans each year and kills about 16,000, and is one of the most expensive cancers to treat. The current treatments for bladder cancer are invasive for patients – who often must sit...
PVM Faculty Pursue Developments in Personalized Medicine to Advance Cancer Treatments
Thursday, October 10th, 2019 - Purdue Veterinary Medicine and Indiana University scientists are working together to find data-driven solutions in the search for better cancer treatments.